Light drives human biology. Morning light sets the daily clock. Daylight supports attention, energy, and mood. Evening darkness supports sleep. Modern routines disrupt that rhythm through indoor lighting, screens, night shifts, and rapid travel. Psychiatry sees the costs. Sleep disruption feeds anxiety. Circadian drift worsens depression. Cognitive speed and motivation fall when sleep timing slips. Most recently, screen time has joined circadian disruptors.

Light as a diagnostic tool

Light already powers diagnosis across medicine. Clinicians shine light through tissue and read the returning signal. Pulse oximetry offers a familiar example. A pulse oximeter sends red light and near infrared light through a fingertip. Hemoglobin absorbs those wavelengths in different proportions depending on oxygen levels. A sensor detects the changing signal with each heartbeat. Software converts the signal into oxygen saturation and pulse rate. Many wearables use a related optical signal to estimate heart rate trends, recovery patterns, and stress proxies from blood volume changes in the skin.

Physics explains why light works for measurement. Light travels as electromagnetic energy. Wavelength defines the type of light. Visible light spans the band the human eye detects. Ultraviolet sits beyond violet. Infrared sits beyond red. Tissue absorbs and scatters each wavelength differently. Blood, water, and pigments each leave a distinct optical signature.

Brain measurement with NIRS

Near infrared light holds special value for brain measurement. Near infrared travels deeper through the head than visible light, since skull and soft tissue scatter less in that band. Near infrared spectroscopy, shortened to NIRS, uses that property. A NIRS system shines near infrared light into the scalp and skull. Detectors capture light that returns after scattering through tissue. Changes in absorption track changes in oxygenated and deoxygenated hemoglobin. Brain cells require a raised energy demand during thinking, feeling, and decision-making. Local blood flow rises to match demand, and hemoglobin signals shift in response.

Functional near infrared spectroscopy, shortened to fNIRS, links those oxygenation changes to brain activation. Neurons fire, local metabolism rises, and local blood flow rises a few seconds later. fNIRS tracks that hemodynamic response on the cortical surface.

fNIRS records during quiet rest and during tasks. Task recordings show how frontal systems respond during attention, working memory, decision-making, and emotional challenge. Many research groups focus on the prefrontal cortex because the region sits close to the skull and drives mood regulation, cognitive control, and stress response.

Depression, anxiety, and cognitive impairment each show characteristic patterns in the research literature. Studies often report lower prefrontal activation during cognitive effort in major depression. Anxiety studies often report altered frontal regulation during emotional stress, along with a different balance between reactivity and control. Cognitive complaints often correlate with inefficient recruitment of frontal networks during demanding tasks. These signatures do not replace the clinical interview. These signatures strengthen clinical reasoning. Patients deserve more than symptom guessing. Clinicians deserve objective signals that add clarity to diagnosis and track response.

Portable systems and care models

Many imaging modalities (CT, MRI, SPECT) require costly facilities and offer limited repeat testing. fNIRS supports repeat measurement in an office setting and tolerates natural movement better than many methods. fNIRS focuses on cortical systems, especially frontal networks, and delivers trends that clinicians review in real time. Repeat scans allow longitudinal monitoring, which matters because brain function shifts with sleep, stress, recovery, and treatment.

Portable fNIRS systems for clinical research, diagnosis, and emerging care models are now a reality. OBELAB, for example, offers a portable fNIRS platform designed for wireless measurement and high-density frontal coverage. Clinicians gain options and match device selection to the clinical question, whether the question involves mood regulation, attention control, cognitive speed, or stress reactivity.

Kernel advances the clinic model with a structured experience and a noninvasive brain measurement session that lasts about 30 minutes, followed by a report and longitudinal tracking. Kernel Flow builds on time domain fNIRS and diffuse optical tomography, aiming for dense measurement. The platform pairs optical brain data with analytic reporting, which supports follow-up testing after interventions. A patient reviews objective changes alongside symptoms, function, and goals.

My office integrates Kernel assessments into psychiatric care and performance work. Executive NeuroShift reflects that integration. The process pairs objective brain function data with clinical history, goals, and a targeted plan. A person arrives with fatigue, low drive, irritability, brain fog, rumination, or stress overload. The assessment records resting patterns and task response, including response to emotional stimuli. Follow-up sessions connect brain metrics with sleep structure, psychotherapy targets, cognitive training, and stress regulation skills. Objective feedback strengthens engagement. Objective feedback improves accountability. Objective feedback accelerates learning.

Light as treatment

Light also treats, not only measures. Bright light therapy uses controlled exposure to intense white light, typically from a light box used in the morning. Morning light strengthens circadian alignment and supports daytime alertness. Bright light therapy is a first-line option for seasonal depression. Evidence now supports adjunct bright light therapy for nonseasonal depression. A recent synthesis of randomized trials reported higher remission and response rates with bright light therapy compared with control conditions, with remission rates around 40 percent in some datasets.

Bright light therapy works through timing, not only brightness. Light signals travel from the retina to brain centers that regulate circadian rhythm, hormone release, and arousal. Morning exposure suppresses melatonin and shifts the body clock earlier. Regular timing builds a stable rhythm, which supports emotional regulation and cognitive efficiency. Clinicians personalize timing based on sleep phase, daily schedule, and symptom pattern. Melatonin, an over-the-counter option, has long been used for sleep disorders also. Ramelteon is FDA approved for insomnia.

This field points toward precision psychiatry built on measurement and feedback. fNIRS offers a repeatable window into frontal brain activation. Bright light therapy offers a targeted intervention that reshapes circadian timing and mood physiology. Health systems gain a pathway toward faster response, fewer failed trials, and clearer patient engagement. Patients deserve objective data paired with humane care. Clinicians deserve tools that measure progress and guide next steps.

Muhamad Aly Rifai is a nationally recognized psychiatrist, internist, and addiction medicine specialist based in the Greater Lehigh Valley, Pennsylvania. He is the founder, CEO, and chief medical officer of Blue Mountain Psychiatry, a leading multidisciplinary practice known for innovative approaches to mental health, addiction treatment, and integrated care. Dr. Rifai currently holds the prestigious Lehigh Valley Endowed Chair of Addiction Medicine, reflecting his leadership in advancing evidence-based treatments for substance use disorders.

Board-certified in psychiatry, internal medicine, addiction medicine, and consultation-liaison (psychosomatic) psychiatry, Dr. Rifai is a fellow of the American College of Physicians (FACP), the American Psychiatric Association (FAPA), and the Academy of Consultation-Liaison Psychiatry (FACLP). He is also a former president of the Lehigh Valley Psychiatric Society, where he championed access to community-based psychiatric care and physician advocacy.

A thought leader in telepsychiatry, ketamine treatment, and the intersection of medicine and mental health, Dr. Rifai frequently writes and speaks on physician justice, federal health care policy, and the ethical use of digital psychiatry.

You can learn more about Dr. Rifai through his Wikipedia page, connect with him on LinkedIn, X (formerly Twitter), Facebook, or subscribe to his YouTube channel. His podcast, The Virtual Psychiatrist, offers deeper insights into topics at the intersection of mental health and medicine. Explore all of Dr. Rifai’s platforms and resources via his Linktree.